PORTUGAL OPEN SUBMENU (SERVIÇOS) SERVIÇOS OPEN SUBMENU (INDÚSTRIAS) INDÚSTRIAS INSIGHTS OPEN SUBMENU (CARREIRAS) CARREIRAS Cookie consent Our website uses cookies to enable basic functionality, analyze visitor traffic, provide social media features and deliver a better user experience. We may also use cookies to help us deliver targeted content and assess the performance of that content and associated campaigns. You may view or change your cookie preferences at any time via the cookie management link found within the footer. For more information, please review our Web Privacy Policy Accept all cookies Decline all cookies Customize cookies ARTICLE CGI helps Montreal Heart Institute find potential treatment for COVID-19 2 min read As the COVID-19 pandemic rapidly spread across the globe in the early months of 2020, the Montreal Heart Institute (MHI) responded by launching a major clinical study to test a potential treatment for the illness. Funded by the Government of Quebec, the new study, called COLCORONA, began on March 23, 2020. More specifically, the MHI set out to evaluate the effectiveness of Colchicine, an anti-inflammatory medicine used for other conditions, in treating adults with severe COVID-19 complications with the goal of reducing hospitalizations and deaths.